Clinical trial
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
NCT00250068 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00250068 |
|---|---|
| Title | Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) |
| Official title | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Diseases, Cancer |
| Intervention type | Drug |
| Interventions | Liposomal 9-Nitrocamptothecin |
| Enrollment | 8 |
| Start date | Apr 1, 2003 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 7, 2005 |
| Last update posted | May 19, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: